$7.59
-0.50-6.18%
In chiusura: -
$7.96
0.374.87%
After hour: 8:33 AM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Lyra Therapeutics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 11
Stima EPS
$-4.830
Stima dei ricavi trimestrali
$136.55K
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$770.00K
Analizza lo storico degli utili di Lyra Therapeutics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
LYRA | Lyra Therapeutics | -$9.00 | -$4.83 | — | — | $195.00K | $136.55K | — | — | 11/11/2025 | |
LYRA | Lyra Therapeutics | -$36.76 | -$5.18 | -$5.51 | -6.37% | $598.00K | $168.75K | $183.00K | 8.44% | 08/12/2025 | |
LYRA | Lyra Therapeutics | -$17.50 | -$6.83 | -$6.50 | 4.83% | $532.00K | $160.00K | $183.00K | 14.37% | 05/06/2025 | |
LYRA | Lyra Therapeutics | -$11.00 | -$6.50 | -$8.00 | -23.08% | $146.00K | $204.80K | $209.00K | 2.05% | 03/13/2025 | |
LYRA | Lyra Therapeutics | -$13.50 | -$11.50 | -$9.00 | 21.74% | $544.00K | $320.00K | $195.00K | -39.06% | 11/12/2024 | |
LYRA | Lyra Therapeutics | -$18.00 | -$16.50 | -$14.50 | 12.12% | $458.00K | $350.00K | $598.00K | 70.86% | 08/14/2024 | |
LYRA | Lyra Therapeutics | -$22.00 | -$13.00 | -$17.50 | -34.62% | $410.00K | $420.00K | $532.00K | 26.67% | 04/30/2024 | |
LYRA | Lyra Therapeutics | -$16.00 | -$15.50 | -$11.00 | 29.03% | $11.00K | $390.00K | $146.00K | -62.56% | 03/21/2024 | |
LYRA | Lyra Therapeutics | -$20.00 | -$16.00 | -$13.50 | 15.62% | $359.00K | $370.00K | $544.00K | 47.03% | 11/07/2023 | |
LYRA | Lyra Therapeutics | -$21.50 | -$21.00 | -$18.00 | 14.29% | $407.00K | $140.00K | $458.00K | 227.14% | 08/08/2023 | |
LYRA | Lyra Therapeutics | -$46.00 | -$18.00 | -$22.00 | -22.22% | $468.00K | $160.00K | $410.00K | 156.25% | 05/12/2023 | |
LYRA | Lyra Therapeutics | -$52.50 | -$20.50 | -$16.00 | 21.95% | $271.00K | $150.00K | $11.00K | -92.67% | 03/29/2023 | |
LYRA | Lyra Therapeutics | -$42.50 | -$22.00 | -$20.00 | 9.09% | $14.00K | $140.00K | $359.00K | 156.43% | 11/08/2022 | |
LYRA | Lyra Therapeutics | -$42.50 | -$18.50 | -$21.50 | -16.22% | $0.00 | $1.44M | $407.00K | -71.74% | 08/09/2022 | |
LYRA | Lyra Therapeutics | -$30.00 | -$45.50 | -$27.00 | 40.66% | $0.00 | $1.25M | $5.37M | 329.36% | 05/10/2022 | |
LYRA | Lyra Therapeutics | -$23.00 | -$48.50 | -$52.50 | -8.25% | $0.00 | — | $271.00K | — | 03/09/2022 | |
LYRA | Lyra Therapeutics | -$24.50 | -$36.50 | -$42.50 | -16.44% | $0.00 | — | $14.00K | — | 11/09/2021 | |
LYRA | Lyra Therapeutics | -$28.00 | -$29.50 | -$42.50 | -44.07% | $0.00 | — | $0.00 | — | 08/09/2021 | |
LYRA | Lyra Therapeutics | -$935.00 | -$24.00 | -$30.00 | -25.00% | $0.00 | — | $0.00 | — | 05/11/2021 | |
LYRA | Lyra Therapeutics | — | -$28.00 | -$23.00 | 17.86% | — | — | $0.00 | — | 03/09/2021 | |
LYRA | Lyra Therapeutics | — | — | -$24.50 | — | — | — | $0.00 | — | 11/10/2020 |
Lyra Therapeutics (LYRA) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-12 | $-5.51 | $-5.18 | -6.37 % |
| Q1 | 2025-05-06 | $-6.50 | $-6.83 | 4.83 % |
| Q4 | 2025-03-13 | $-8.00 | $-6.50 | -23.1 % |
| Q3 | 2024-11-12 | $-9.00 | $-11.50 | 21.7 % |
Lyra Therapeutics (LYRA) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-12 | $183.00K | $168.75K | 8.44 % |
| Q1 | 2025-05-06 | $183.00K | $160.00K | 14.4 % |
| Q4 | 2025-03-13 | $209.00K | $204.80K | 2.05 % |
| Q3 | 2024-11-12 | $195.00K | $320.00K | -39.1 % |
FAQ
Quando Lyra Therapeutics (NASDAQ:LYRA) riporterà gli utili?
Si prevede che Lyra Therapeutics (LYRA) fornisca risultati il novembre 11, 2025. Gli ultimi risultati sono stati pubblicati il agosto 12, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Lyra Therapeutics (NASDAQ:LYRA)?
L'EPS effettivo era $-5.51, che mancato la stima di $-5.18.
Quali sono state le entrate di Lyra Therapeutics (NASDAQ:LYRA)?
Le entrate effettive sono state $183K, che superato la stima di $168.8K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.